|
Identifying Therapeutic Targets to Prevent Progression of Familial RUNX1 Disorder to AML Using Novel iPSC Models |
Icahn School of Medicine at Mount Sinai |
The RUNX1 Research Program |
|
Genetic Dissection of Cytogenetically Normal AML |
Cincinnati Children's Hospital Medical Center |
Northwestern Mutual Foundation |
|
Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations |
Stanford University |
The RUNX1 Research Program |
|
Identification of Hypoxia-induced Pathways Driving Ewing sarcoma Metastases |
Georgetown University |
Northwestern Mutual Foundation |
|
Restoring RUNX1 Levels in FPD/AML |
University of Washington, Seattle |
The RUNX1 Research Program |
|
Optimizing Conformation Disrupting Aurora Kinase Inhibitors to Treat MYCN Amplified Neuroblastoma |
University of California San Francisco |
Northwestern Mutual Foundation |
|
Studies of Invadopodia Formation in Ewing sarcoma |
University of Michigan |
Northwestern Mutual Foundation |
|
Validating a Mouse Model of Alveolar Rhabdomyosarcoma |
Duke University |
Northwestern Mutual Foundation |
|
Developing Targeted Immunotherapy Against Pediatric Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center |
I Care I Cure |
|
The Role of MiRNA Impairment in Wilms' Tumor Formation |
University of Texas Southwestern Medical Center at Dallas |
Sydney Harper Foundation |
